These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 15977144

  • 21. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA.
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [Abstract] [Full Text] [Related]

  • 22. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF.
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [Abstract] [Full Text] [Related]

  • 23. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
    Berding G, Schicha H.
    Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
    [Abstract] [Full Text] [Related]

  • 24. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Nowak B, Ostwald E, Schäfer W, Block S, Setani K, Büll U.
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [Abstract] [Full Text] [Related]

  • 29. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
    Nucl Med Rev Cent East Eur; 2016 Feb; 19(1):3-11. PubMed ID: 26841373
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J, Kubinyi J, Telička Z.
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [Abstract] [Full Text] [Related]

  • 32. Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial.
    Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedüs L.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2946-51. PubMed ID: 16735487
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU, De Freitas Gomes E, Bae SH, Ulyssea R, Casulari LA.
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
    Gómez-Arnaiz N, Andía E, Gumà A, Abós R, Soler J, Gómez JM.
    Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI, Dumitriu L, Grigorie D, Simescu M, Vaida E, Belgun M, Popovici D.
    Rom J Endocrinol; 1993 Aug; 31(3-4):155-63. PubMed ID: 7697064
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.